ABSTRACT • Objective : To examine the epidemiological
and clinical characteristics of children diagnosed with HenochSchönlein purpura (HSP) and to compare them with other areas in the world. Methods : The medical records of children with HSP were retrospectively reviewed at the Jordan University Hospital between the years 1998 and 2012. The clinical and demographical features, laboratory tests, management and outcome were assessed. Results : There were 55 children with HSP, with a mean age of 7 years (60% were males) ; 85.4% of patients were less than 10 years ; 72.7% of cases presented during the winter and autumn. There was a history of antecedent upper respiratory tract infection in 49.1% of cases ; 32.7% of children had more than one hospitalization. Purpuric skin rash was seen in 100%, abdominal pain in 74.5%, arthritis in 58.2%, renal involvement in 30.9% of patients. In four patients HSP was the presenting feature of familial Mediterranean fever (FMF). Conclusion : HSP is a benign and self-limiting disease with an excellent prognosis. There are no significant differences in the epidemiological and clinical profile than reported elsewhere.
Keywords [16] , were used for the diagnosis of HSP, and it included palpable purpura (a mandatory criterion) and the presence of at least one of the following: (1) diffuse abdominal pain, (2) any biopsy showing predominant IgA deposition, (3) arthritis or arthralgia, and (4) renal involvement (hematuria and/or proteinuria).
The data extracted from the medical records included demographical features as age, gender, month and year of presentation, antecedent upper respiratory tract infection within two weeks of diagnosis and clinical manifestations of the disease as skin rash, arthritis, gastrointestinal symptoms as abdominal pain, melena, vomiting and renal involvement as the presence of macroscopic hematuria, microscopic hematuria, combined hematuria and non nephrotic range proteinuria, or nephrotic syndrome. The type of treatment used, recurrence, number of hospital admissions, average length of hospital stay and months of follow-up were also recorded.
Laboratory data collected included urine analysis, stool for occult heme, abdominal ultrasound, antistreptolysin O (ASO) titer, throat culture, skin or kidney biopsy.
Statistical analysis
Continuous variables as age were expressed as mean, median, and range. Statistical analysis of categorical data was performed using the chi square test. Statistical significance was taken as p < .05. All statistical analysis was performed using (SPSS 16). (Table I) During the years 1998 to 2012, there were 55 (33 boys) cases of HSP admitted to JUH.
RESULTS

Epidemiological features
72.7% of cases presented during the winter and autumn. There was a history of antecedent upper respiratory tract infection in 49.1% of patients. 32.7% of patients had more than one hospitalization due to the emergence of new symptoms of the disease as recurring rash, abdominal pain, arthritis. The mean length of hospital stay was 6.3 days (range 1-18). Twenty-seven patients had follow-up with a mean period of five months. (Table II) All patients had the typical purpuric skin rash on the extensor surfaces of the lower limbs and buttocks. Facial distribution of the rash was seen in five cases, and one patient had a rash over the trunk. Two cases had bulbous rash of HSP, one of them was proven by biopsy to be leucocytoclastic vasculitis. The bulbous lesions became hemorrhagic and later on necrotic with crusts. Skin biopsy was done in five of our patients and showed features of leucocytoclastic vasculitis.
Clinical features
Abdominal pain was seen in 74.5% of cases. Sixteen patients had an ultrasound that was normal, barium enema was needed in one of our patients with the suspicion of intussusception and it was normal. Steriods were used in these patients and all of them had a favorable response.
Renal involvement was seen in 30.9% of patients. Most of the patients had these renal abnormalities at presentation of the disease except for four patients who presented after a period of two weeks to two months. Two had nephrotic syndrome. One presented one month after the onset: he had hypoalbuminemia with normal blood pressure and normal creatinine and a kidney biopsy showing mesangiocapillary glomerulonephritis with IgA and C3 deposits; he was given steroids for four months with complete resolution of proteinuria after three months, The other patient had nephrotic proteinuria and hypertension with normal creatinine one month after the presentation, but didn't have a kidney biopsy; he was given steroids and cyclosporine and responded; his proreinuria resolved after a month.
Another patient who had HSP at 7.5 years with transient microscopic hematuria represented six years later with gross hematuria and nephrotic range proteinuria. A kidney biopsy showed mesangioproliferative glomerulonephritis with IgA and C3 deposits. He was given antiproteinuric agents, was followed for four years and the proteinuria resolved.
Arthritis was seen in 32 patients (58.2%). Upper and lower limb arthritis was seen in nine patients and 19 patients had lower limb arthritis only. Ankles were the most common joints involved.
There were no statistically significant differences between the frequency of abdominal pain, arthritis, and renal involvement according to different age groups as shown in Table III .
Central nervous system complications were seen in two patients. One had severe headache and underwent brain imaging and was found to be normal. The other The European League against Rheumatism/Pediatric Rheumatology European Society (EULAR/LPReS) criteria, published in 2006 [16] , were used for the diagnosis of HSP, and it included palpable purpura (a mandatory criterion) and the presence of at least one of the following: (1) diffuse abdominal pain, (2) any biopsy showing predominant IgA deposition, (3) arthritis or arthralgia, and (4) renal involvement (hematuria and/or proteinuria).
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RESULTS
Epidemiological features
72.7% of cases presented during the winter and autumn.
There was a history of antecedent upper respiratory tract infection in 49.1% of patients. 32.7% of patients had more than one hospitalization due to the emergence of new symptoms of the disease as recurring rash, abdominal pain, arthritis. The mean length of hospital stay was 6.3 days (range 1-18). Twenty-seven patients had follow-up with a mean period of five months. (Table II) All patients had the typical purpuric skin rash on the extensor surfaces of the lower limbs and buttocks. Facial distribution of the rash was seen in five cases, and one patient had a rash over the trunk. Two cases had bulbous rash of HSP, one of them was proven by biopsy to be leucocytoclastic vasculitis. The bulbous lesions became hemorrhagic and later on necrotic with crusts. Skin biopsy was done in five of our patients and showed features of leucocytoclastic vasculitis.
Clinical features
Central nervous system complications were seen in two patients. One had severe headache and underwent brain imaging and was found to be normal. The other case was a 9-year-old boy who developed confusion, headache and had a complex partial seizure, during his hospital stay. Brain MRI showed abnormal subcortical hyperintense signals in both parietal lobes; he was given pulse methylprednisolone and cyclophosphamide for his central nervous system vasculitis. Scrotal swelling was seen in seven patients (12.7%), all of them had an ultrasound showing features of epididymo-orchitis. One patient had an exploration and was found to have epididymo-orchitis without evidence of torsion. Most of the testicular swelling resolved within two days.
Ibuprofen was used in 25.5% of patients. Steroids were used in 47.5% of cases for severe abdominal pain. Recurrence of HSP was seen in 7 patients (12.7%) .
Four of our patients were diagnosed to have familial Mediterranean fever (FMF), two of them were diagnosed few years later because they presented with recurrent abdominal pain and purpuric skin rash, and had a heterozygote mutation of M694V. One had a prolonged course of HSP and was found to have a heterozygote mutation of P369S. Another child had a severe HSP with central nervous system involvement in the form of seizures along with nephrotic range proteinuria and a heterozygote mutation of M694V. Three of these patients with FMF and HSP were hospitalized three times.
Six patients who presented with HSP before the year 2002 were suspected of having FMF because they presented later with recurrent purpura and abdominal pain but no genetic testing was done for them.
ASO titer was positive in 36.8% (7/19) of those tested. Throat culture grew group A B hemolytic streptococcus in three patients out of nine tested. DISCUSSION HSP is the most common vasculitis in children. The demographic and clinical characteristics of 55 cases were reviewed. Mean age was 7 years and that is similar to other studies [10, 17] but younger than in studies from Turkey and the southern part of Saudi Arabia [11, 18, 19] where the mean age was above 8. Around 85.4% of children were less than 10 years of age. There were 33 boys with a M:F ratio of 1.5:1 which is similar to other studies [10, [17] [18] [19] , although Harbi et al. found nearly almost equal sex distribution [11] .
HSP occurs all year round, but many studies have found a seasonal variation [3, 17, 18] . In our study 72.7% of cases occurred during the winter and autumn supporting an infectious trigger in the pathogenesis of HSP; 49.1% had a previous upper respiratory tract infection (URTI) as in previous studies [10, 17] ; 36.8% had positive ASO titers and three patients grew cultures of group A B hemolytic streptococuss. A study from Jordan in 1996 found a significant difference in ASO titer in HSP patients in comparison to control cases [3] . In our study, a third had more than one hospitalization due to the emergence or worsening of new symptoms; this high rate of rehospitalization can be decreased by proper education and counseling of the disease and its manifestations.
In our study 50.9% were lost for follow-up, and the recurrence rate was similar to other studies [10, 18] .
Purpuric skin rash was seen in all patients, however two patients had bulbous type of HSP with hemorrhage. There are few case reports describing children with HSP who had bullae [20] and in a review by Saulsbury in 1990, 2% had hemorrhagic bullae [21] .
Gastrointestinal involvement and abdominal pain was seen in 74.5% and that is described in other studies [13, 22, 23] . No patients had intussusception. Renal involvement was seen in 30.9% of patients with the majority of patients having microscopic hematuria. Two had nephrotic syndrome. Renal involvement in HSP usually develops within three months in 97-100% of cases [1] and its incidence varies from 10-50% with end-stage renal diseae in less than 5% [17, 24] . Eighty-eight percent of our patients with renal involvement were > 5 years but there was no statistical significance between age groups regarding the frequency of renal involvement as was observed in other studies [19] . Sano et al. showed that an age of more than 4 years at onset, severe abdominal pain with gastrointestinal bleeding, persistent purpura over a month, were associated with renal involvement [25] .
Many other studies have also found that the incidence, severity and degree of renal involvement increases with age [15, 17, [26] [27] [28] .
We had a patient who had HSP and microscopic hematuria who after several years developed IgA nephropathy, pointing that these two diseases share a common pathogenesis. There are reports of patients with IgA nephropathy who later developed HSP [29, 30] and patients who had HSP who represented later with IgA nephropathy [31] .
Arthritis is the second common manifestation of HSP [5] . It was seen in 58.2% of our patients with the ankle and knee joints most commonly affected; 58% had localized edema which is similar to other studies [3, 17] , but higher than observed in Saudi Arabia [10] and Turkey [18] . The difference might be due to misdiagnosis between arthritis and periarticular soft tissue edema that would have happened due to the retrospective nature of the study.
Cerebral vasculitis is seen in HSP [32] . Headache and mental status changes are the most frequent neurological abnormalities followed by seizures [33] .
Testicular swelling was seen in 12.7% of patients and only one needed exploration. There is variability in the incidence of orchitis in HSP ranging from 2-38% [34] and ultrasound is the gold standard test to rule out torsion in these patients.
In four of our patients, HSP was the presenting symptom of FMF; they had a more severe form of the disease with multiple hospitalizations. The incidence of FMF in the study group was 7.2%, higher than in other studies [19] . HSP occurred in 5% of patients with FMF [35, 36] . Studies from the Middle East have found HSP occurring in 3-7% of FMF patients [37] . IgA nephropathy has been reported in adults with FMF from Jordan [38] .
One of our patients with a rarely seen heterozygote P369S mutation in MEFV gene had a prolonged course of the disease. Another case was reported with this mutation with renal and gastrointestinal involvement [39] .
Studies from Turkey have looked at the frequency of FMF mutations in children with HSP who did not fit the criteria for diagnosis of FMF. They found that around 30% of HSP patients had a heterozygote mutation in the MEFV gene; that M694V was the most common mutation and that these patients had more clinical features and abnormal inflammatory markers than other children with HSP [40, 41] . The high carrier rate and prevalence of FMF in Arabs [42] should allow us to think of FMF in atypical and severe cases of HSP. The association between FMF and HSP is probably due to the upregulation of the inflammatory response in children with FMF that predisposes to vasculitis [32, 37] .
CONCLUSION
Henoch-Schönlein purpura is a benign self-limiting disease and usually has an excellent prognosis. The demographical and clinical features in our study did not differ substantially from other areas in the Middle East. The possibility of familial Mediterranean fever should be considered in patients who have severe or prolonged course of the disease.
